Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort

Jeffrey J. Tosoian, Mufaddal Mamawala, Jonathan I. Epstein, Patricia Landis, Katarzyna J. Macura, Demetrios N. Simopoulos, H. Ballentine Carter, Michael A. Gorin

Research output: Contribution to journalArticle


Men with grade group 1 prostate cancer electing active surveillance are at minimal risk of cancer mortality or metastasis over long-term follow-up. Additional data will characterize the safety of active surveillance in higher-risk patients and better optimize the use of noninvasive testing.

Original languageEnglish (US)
JournalEuropean Urology
StateAccepted/In press - Jan 1 2020



  • Active surveillance
  • Low-risk prostate cancer
  • Magnetic resonance imaging
  • Prostate biopsy
  • Prostate-specific antigen
  • Very-low-risk prostate cancer

ASJC Scopus subject areas

  • Urology

Cite this